Dawes Fretzin Clinical Research Group

Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial

Alice B. Gottlieb, Alan Menter, Alan M. Mendelsohn et al. · The Lancet · 2009 · 583 citations

Medicine, Clinical Sciences, Immunology +15

IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis

James G. Krueger, Scott Fretzin, Mayte Suárez‐Fariñas et al. · Journal of Allergy and Clinical Immunology · 2012 · 380 citations · Full text

Life Sciences, Dermatology, Immunology +14

Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasis

Caitriona Ryan, Alan Menter, Lyn Guenther et al. · British Journal of Dermatology · 2018 · 119 citations · Full text

Medicine, Dermatology, Pharmacotherapy +13

Patients’ Perspectives on the Impact of Genital Psoriasis: A Qualitative Study

Jennifer Clay Cather, Caitriona Ryan, K.A.P. Meeuwis et al. · Dermatology and Therapy · 2017 · 65 citations · Full text

Medicine, Dermatology, Dermatopathology +10

Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides)

Ellen J. Kim, Aaron R. Mangold, Jennifer DeSimone et al. · JAMA Dermatology · 2022 · 51 citations · Full text

Medicine, Dermatology, Oncology +9